European Leukemia Trial Registry
Trial: ALL GMALL Allo-SCT-Treo-VP16-Cyclo in ALL

More Details
Title Allogeneic Stem Cell Transplantation with Treosulfan, VP-16 and Cyclophosphamide for patients with ALL
Scientific Title Allogeneic Stem Cell Transplantation with Treosulfan, VP-16 and Cyclophosphamide for patients with Acute Lymphoblastic Leukemia (ALL) not eligible for TBI-containing regimen: A phase II study
Short Title ALL GMALL Allo-SCT-Treo-VP16-Cyclo in ALL
Trialgroup GMALL
Type of Trial multicentric
Disease Acute lymphoblastic leukemia(ALL) Stem cell transplantation
Stem cell transplantation(SCT) ALL
Age <= 65 years
Status Closed
Start of Recruitment 06.07.2007
Leader Kröger, Prof. Dr. med., Nicolaus
Contactperson

principal investigator
Kröger, Prof. Dr. med., Nicolaus
Tel: +49 (0)40 42803 5864
Fax: +49 (0)40 42803 3795
Email: nkroeger@uke.uni-hamburg.de

principal investigator
Beelen, Prof. Dr., Dietrich W.

Study Centre
Heinzelmann, Marion

Shortprotocol Shortprotocol
created 29.07.2008 5 Roswitha Kotthoff
changed 21.01.2016 Zenawit Krüger
© ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org